The Ohio House of Representatives advanced two pro-life measures on Wednesday aimed at curbing chemical abortions and educating students on fetal development.
The pro-life bills are drawing praise from advocates who hailed the votes as a victory for mothers and unborn children.
House Bill 324, dubbed the Patient Protection Act, cleared the chamber 59-28. The legislation would classify the abortion drug mifepristone as a “dangerous drug” due to its severe side effects in more than 5% of patients. It prohibits mail-order sales and remote prescribing, requiring women to visit a doctor in person for informed consent about the risks.
